# Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

> **NCT05323201** · PHASE1,PHASE2 · RECRUITING · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 15 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** fhB7H3.CAR-Ts
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT05323201
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-10
- **Primary completion:** 2024-02-10
- **Final completion:** 2027-02-10
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2022-04-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05323201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05323201, "Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05323201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*